Alexandria Real Estate Equities
ARE
$119.49
Share price
0.78%
Change (1 day)
-3.68%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - P/B ratio
P/B ratio as of April 2024 : 0.9241
According to Alexandria Real Estate Equities
's latest financial reports the company has a price-to-book ratio of 0.9241.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Alexandria Real Estate Equities - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9738 | -7.59% |
| 2022-12-31 | 1.05 | -43.08% |
| 2021-12-31 | 1.85 | 3.49% |
| 2020-12-31 | 1.79 | -6.82% |
| 2019-12-31 | 1.92 | 18.48% |
| 2018-12-31 | 1.62 | -16.56% |
| 2017-12-31 | 1.94 | 18.44% |
| 2016-12-31 | 1.64 | 7.4% |
| 2015-12-31 | 1.53 | -5.88% |
| 2014-12-31 | 1.62 | 42.54% |
| 2013-12-31 | 1.14 | -9.07% |
| 2012-12-31 | 1.25 | 0.55% |
| 2011-12-31 | 1.24 | -7.69% |
| 2010-12-31 | 1.35 | 15.1% |
| 2009-12-31 | 1.17 | 4.89% |
| 2008-12-31 | 1.12 | -47.73% |
| 2007-12-31 | 2.14 | 3.36% |
| 2006-12-31 | 2.07 | -2.75% |
| 2005-12-31 | 2.13 | -9.56% |
| 2004-12-31 | 2.35 | 6.86% |
| 2003-12-31 | 2.20 | 32.2% |
| 2002-12-31 | 1.66 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.67 | 80.63% | 🇺🇸 USA |
 Eli Lilly LLY | 65.3 | 6,962.39% | 🇺🇸 USA |
 Amgen AMGN | 23.5 | 2,447.78% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.67 | 297.61% | 🇺🇸 USA |
 Illumina ILMN | 3.45 | 273.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.37 | 264.42% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -83.7 | -9,159.24% | 🇺🇸 USA |